ISRG — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates ISRG as Neutral with 77% confidence in the Healthcare sector.
AI Analysis Summary
ISRG is overvalued with deteriorating technicals and negative forecast, warranting a bearish stance despite strong fundamentals.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 45/100
- Bill Ackman (Activist Investing): Grade D — 45/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $482.22
- Price target: $473.33 (-1.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: strong
- Cash flow: good
- Competitive moat: brand power
Peer Group Analysis
ISRG is in the “Quality Cash Generators” cluster alongside YUM, WYNN, USB, VICI, V (96 stocks total). 2 of 96 peers are currently bullish.